image credit: Adobe Stock

J&J joins pharma allies in challenging US drug pricing law

July 19, 2023


The U.S. has long been the most lucrative market for pharmaceutical makers, in part because there are no mechanisms such as price negotiations to control the cost of medicines. As a result, Americans pay more than three times as much for brand-name drugs than people in other parts of the world, according to a 2021 Rand Corporation study funded by the U.S. government.

Read More on Biopharma Dive